BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26979803)

  • 1. Chromatin interactions and candidate genes at ten prostate cancer risk loci.
    Du M; Tillmans L; Gao J; Gao P; Yuan T; Dittmar RL; Song W; Yang Y; Sahr N; Wang T; Wei GH; Thibodeau SN; Wang L
    Sci Rep; 2016 Mar; 6():23202. PubMed ID: 26979803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
    Jin HJ; Jung S; DebRoy AR; Davuluri RV
    Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3C-digital PCR for quantification of chromatin interactions.
    Du M; Wang L
    BMC Mol Biol; 2016 Dec; 17(1):23. PubMed ID: 27923366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome.
    Du M; Yuan T; Schilter KF; Dittmar RL; Mackinnon A; Huang X; Tschannen M; Worthey E; Jacob H; Xia S; Gao J; Tillmans L; Lu Y; Liu P; Thibodeau SN; Wang L
    Hum Mol Genet; 2015 Jan; 24(1):154-66. PubMed ID: 25149474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prostate cancer risk locus at 10q11 is associated with DNA repair capacity.
    Rinckleb AE; Surowy HM; Luedeke M; Varga D; Schrader M; Hoegel J; Vogel W; Maier C
    DNA Repair (Amst); 2012 Aug; 11(8):693-701. PubMed ID: 22677538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Nucleotide Polymorphisms Sequencing Identifies Candidate Functional Variants at Prostate Cancer Risk Loci.
    Zhang P; Tillmans LS; Thibodeau SN; Wang L
    Genes (Basel); 2019 Jul; 10(7):. PubMed ID: 31323811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Functional Variants at 13q14 Risk Locus for Osteoporosis Regulate RANKL Expression Through Long-Range Super-Enhancer.
    Zhu DL; Chen XF; Hu WX; Dong SS; Lu BJ; Rong Y; Chen YX; Chen H; Thynn HN; Wang NN; Guo Y; Yang TL
    J Bone Miner Res; 2018 Jul; 33(7):1335-1346. PubMed ID: 29528523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants.
    Spisák S; Lawrenson K; Fu Y; Csabai I; Cottman RT; Seo JH; Haiman C; Han Y; Lenci R; Li Q; Tisza V; Szállási Z; Herbert ZT; Chabot M; Pomerantz M; Solymosi N; ; Gayther SA; Joung JK; Freedman ML
    Nat Med; 2015 Nov; 21(11):1357-63. PubMed ID: 26398868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.
    Huang Q; Whitington T; Gao P; Lindberg JF; Yang Y; Sun J; Väisänen MR; Szulkin R; Annala M; Yan J; Egevad LA; Zhang K; Lin R; Jolma A; Nykter M; Manninen A; Wiklund F; Vaarala MH; Visakorpi T; Xu J; Taipale J; Wei GH
    Nat Genet; 2014 Feb; 46(2):126-35. PubMed ID: 24390282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive functional annotation of 77 prostate cancer risk loci.
    Hazelett DJ; Rhie SK; Gaddis M; Yan C; Lakeland DL; Coetzee SG; ; ; Henderson BE; Noushmehr H; Cozen W; Kote-Jarai Z; Eeles RA; Easton DF; Haiman CA; Lu W; Farnham PJ; Coetzee GA
    PLoS Genet; 2014 Jan; 10(1):e1004102. PubMed ID: 24497837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
    Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
    PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer.
    Zuber V; Bettella F; Witoelar A; ; ; ; ; Andreassen OA; Mills IG; Urbanucci A
    BMC Genomics; 2017 Mar; 18(1):270. PubMed ID: 28359301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci.
    Chen H; Yu H; Wang J; Zhang Z; Gao Z; Chen Z; Lu Y; Liu W; Jiang D; Zheng SL; Wei GH; Issacs WB; Feng J; Xu J
    Prostate; 2015 Sep; 75(12):1264-76. PubMed ID: 26015065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic insights into genetic susceptibility to prostate cancer.
    Tian P; Zhong M; Wei GH
    Cancer Lett; 2021 Dec; 522():155-163. PubMed ID: 34560228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate genes for prostate cancer-risk SNPs utilizing a normal prostate tissue eQTL data set.
    Thibodeau SN; French AJ; McDonnell SK; Cheville J; Middha S; Tillmans L; Riska S; Baheti S; Larson MC; Fogarty Z; Zhang Y; Larson N; Nair A; O'Brien D; Wang L; Schaid DJ
    Nat Commun; 2015 Nov; 6():8653. PubMed ID: 26611117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic analysis of chromatin interactions at disease associated loci links novel candidate genes to inflammatory bowel disease.
    Meddens CA; Harakalova M; van den Dungen NA; Foroughi Asl H; Hijma HJ; Cuppen EP; Björkegren JL; Asselbergs FW; Nieuwenhuis EE; Mokry M
    Genome Biol; 2016 Nov; 17(1):247. PubMed ID: 27903283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional Candidate Genes for Human Atherosclerotic Disease Identified Through Annotation Based on Chromatin Organization.
    Haitjema S; Meddens CA; van der Laan SW; Kofink D; Harakalova M; Tragante V; Foroughi Asl H; van Setten J; Brandt MM; Bis JC; O'Donnell C; Cheng C; Hoefer IE; Waltenberger J; Biessen E; Jukema JW; Doevendans PA; Nieuwenhuis EE; Erdmann J; Björkegren JL; Pasterkamp G; Asselbergs FW; den Ruijter HM; Mokry M
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28320757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.
    Winter JM; Curry NL; Gildea DM; Williams KA; Lee M; Hu Y; Crawford NPS
    BMC Genomics; 2018 Jun; 19(1):450. PubMed ID: 29890952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus.
    Cai M; Kim S; Wang K; Farnham PJ; Coetzee GA; Lu W
    Sci Rep; 2016 Mar; 6():22462. PubMed ID: 26934861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.